Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Capital Expenditures (2022 - 2026)

Axsome Therapeutics' Capital Expenditures history spans 5 years, with the latest figure at $121000.0 for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 64.2% to $121000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $263000.0, a 48.43% decrease, with the full-year FY2025 number at $480000.0, up 77.78% from a year prior.
  • Capital Expenditures hit $121000.0 in Q1 2026 for Axsome Therapeutics, up from $71000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for AXSM hit a ceiling of $371000.0 in Q3 2023 and a floor of $7000.0 in Q4 2023.
  • Historically, Capital Expenditures has averaged $126764.7 across 5 years, with a median of $90000.0 in 2024.
  • The widest YoY moves for Capital Expenditures: up 462.12% in 2023, down 96.13% in 2023.
  • Tracing AXSM's Capital Expenditures over 5 years: stood at $181000.0 in 2022, then plummeted by 96.13% to $7000.0 in 2023, then surged by 328.57% to $30000.0 in 2024, then surged by 136.67% to $71000.0 in 2025, then soared by 70.42% to $121000.0 in 2026.
  • Business Quant data shows Capital Expenditures for AXSM at $121000.0 in Q1 2026, $71000.0 in Q4 2025, and $58000.0 in Q3 2025.